Innameomly,
Why does it have to be a hostile takeover. Most biotech takeovers are negotiated trade sales. I can’t remember the last time I saw a hostile takeover in this space
The acquirer normally like to get the team to come over to bring the expertise! This is much easier in a negotiated buyout. The staff all get the performance bonuses and are happy to help finish the development with a new owner. And get to negotiate new employment contracts.
Innameomly, Why does it have to be a hostile takeover. Most...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.360(2.59%) |
Mkt cap ! $1.733B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $6.421M | 470.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1643 | $13.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 3100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |